Lobenzarit disodium inhibits the constitutive NO-cGMP metabolic pathways. Possible involvement as an immunomodulatory drug

• Main Authors: J. Padrón (Author), A. Rojas (Author), L. Glaría (Author), L. Caveda (Author), R. Delgado (Author), M. Torres (Author), O. Martínez (Author), E. López (Author), A. Beltrán (Author), M. Palacios (Author)
• Format: Book
• Published: Hindawi Limited, 1995-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lobenzarit disodtulIl (CCA) is a novel immunomodulatory drug useful in the treatment of chronic inflammations. Its principal mechanism of action seems to be through enhancing the T suppressor/T helper lymphocyte ratio. However, the molecular basis for these actions remains unclear. In this study it...